Thermo Fisher Scientific Reports Second Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Thermo Fisher Scientific (TMO) Tops Q2 EPS by 4c; Raises FY19 EPS/Revenue Guidance
July 24, 2019 6:07 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $3.04, $0.04 better than the analyst estimate of $3.00. Revenue for the quarter came in at $6.32 billion versus the consensus estimate of $6.3 billion.
Second Quarter 2019 Highlights
Second quarter revenue increased 4% to $6.32 billion.Second quarter GAAP diluted earnings per share (EPS) increased 50% to $2.77.Second quarter adjusted EPS increased 11% to $3.04.Strengthened our mass spectrometry leadership with new instruments, workflows and software, highlighted by two new-generation Thermo Scientific Orbitrap systems the Exploris 480 and Eclipse Tribrid and a new workflow to advance biotherapeutics, called the HR Multi-Attribute Method.... More